National Taiwan University Hospital (NTUH) has consulted with the United States and is to start clinical trials in Taiwan of the antiviral drug remdesivir for the treatment of COVID-19 coronavirus, the Central Epidemic Command Center (CECC) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Maserati driver, passenger who beat man into a coma lose appeals
07/31/2026 05:05 PM - Business
Taiwan's manufacturing sector continued to grow in June
07/31/2026 04:40 PM - Business
Taiex posts record one-day point gain as TSMC hits 10% limit
07/31/2026 03:47 PM - Society
Ministry says empty egg shelves do not indicate shortage
07/31/2026 02:09 PM - Business
Taiwan shares close up 7.98%
07/31/2026 01:49 PM